Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Lepromatous leprosy
MeSH D015440 - lepromatous leprosy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D056006:
Multibacillary leprosy
0 Companies
0 Drugs
Success rate
D015440:
Lepromatous leprosy
19 Companies
2 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novartis
Clofazimine
Lamprene
1986-12-15
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
2/2
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Taro Pharmaceutical
Dapsone
Almirall
Dapsone
Novartis
Clofazimine
Torrent Pharmaceuticals
Dapsone
Allergan
Dapsone
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use